{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:27:50Z","timestamp":1790857670639,"version":"4.1.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":3053,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.breast.2011.02.019","type":"journal-article","created":{"date-parts":[[2011,3,17]],"date-time":"2011-03-17T04:47:53Z","timestamp":1300337273000},"page":"205-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The female breast and diabetes"],"prefix":"10.1016","volume":"20","author":[{"given":"Evanthia","family":"Gouveri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Papanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstratios","family":"Maltezos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2011.02.019_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.diabres.2009.11.006","article-title":"The IDF Diabetes Atlas: providing evidence, raising awareness and promoting action","volume":"87","author":"Unwin","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.breast.2011.02.019_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jdiacomp.2008.12.009","article-title":"The diabetic hand: a forgotten complication?","volume":"24","author":"Papanas","year":"2010","journal-title":"J\u00a0Diabetes Complications"},{"key":"10.1016\/j.breast.2011.02.019_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0140-6736(84)92114-7","article-title":"Fibrous disease of the breast, thyroiditis, and cheiroarthropathy in type 1 diabetes mellitus","volume":"1","author":"Soler","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2011.02.019_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF00279127","article-title":"Medial arterial calcification and its association with mortality and complications of diabetes","volume":"31","author":"Everhart","year":"1988","journal-title":"Diabetologia"},{"key":"10.1016\/j.breast.2011.02.019_bib5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.amjcard.2004.05.036","article-title":"Prevalence and determinants of breast arterial calcium in women at high risk of cardiovascular disease","volume":"94","author":"Mass","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.breast.2011.02.019_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jdiacomp.2004.04.004","article-title":"Breast arterial calcifications associated with diabetes and hypertension","volume":"18","author":"Cetin","year":"2004","journal-title":"J\u00a0Diabetes Complications"},{"key":"10.1016\/j.breast.2011.02.019_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/jsre.2002.6449","article-title":"The need for a multidisciplinary approach to cancer care","volume":"105","author":"Ko","year":"2002","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.breast.2011.02.019_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00592-010-0187-3","article-title":"Epidemiological aspects of neoplasms in diabetes","volume":"47","author":"Nicolucci","year":"2010","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.breast.2011.02.019_bib9","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ijc.22717","article-title":"Diabetes mellitus and risk of breast cancer: a meta-analysis","volume":"121","author":"Larsson","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.breast.2011.02.019_bib10","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1517\/13543784.2010.499122","article-title":"Metformin and cancer: licence to heal?","volume":"19","author":"Papanas","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.breast.2011.02.019_bib11","first-page":"448","article-title":"Diabetic mastopathy, complication of type 1 diabetes mellitus: report of two cases and a review of the literature","volume":"24","author":"Boullu","year":"1998","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.breast.2011.02.019_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11892-003-0054-5","article-title":"Mastopathy and diabetes","volume":"3","author":"Kudva","year":"2003","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.breast.2011.02.019_bib13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.clinimag.2008.12.003","article-title":"Diabetic mastopathy mimicking breast cancer","volume":"33","author":"Murakami","year":"2009","journal-title":"Clin Imaging"},{"key":"10.1016\/j.breast.2011.02.019_bib14","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1447-0756.2009.01146.x","article-title":"Fibrous mastopathy: clinical, imaging, and istopahtologic findings of 31 cases","volume":"36","author":"Pereira","year":"2010","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.breast.2011.02.019_bib15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1309\/K5HM-9603-PQ5T-KY3F","article-title":"Diabetic mastopathy. A clinicopathologic review","volume":"113","author":"Ely","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.breast.2011.02.019_bib16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF02967661","article-title":"Diabetic mastopathy in an advanced elderly woman with insulin-dependent type 2 diabetes mellitus","volume":"10","author":"Kojima","year":"2003","journal-title":"Breast Cancer"},{"key":"10.1016\/j.breast.2011.02.019_bib17","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2169\/internalmedicine.46.6191","article-title":"Diabetic mastopathy of bilateral breasts in an elderly Japanese woman with 2 diabetes: a case report and a review of the literature in Japan","volume":"46","author":"Honda","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.breast.2011.02.019_bib18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2325\/jbcs.13.205","article-title":"An uncommon case of diabetic mastopathy in type II non-insulin dependent diabetes mellitus","volume":"13","author":"Sotome","year":"2006","journal-title":"Breast Cancer"},{"key":"10.1016\/j.breast.2011.02.019_bib19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF02967660","article-title":"A\u00a0case of diabetic mastopathy with multiple lesions mimicking breast cancer","volume":"10","author":"Utada","year":"2003","journal-title":"Breast Cancer"},{"key":"10.1016\/j.breast.2011.02.019_bib20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1524-4741.2006.00345.x","article-title":"Painful diabetic mastopathy as a reason for mastectomy","volume":"12","author":"Perret","year":"2006","journal-title":"Breast J"},{"key":"10.1016\/j.breast.2011.02.019_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000318641","article-title":"Diabetic mastopathy: a case report and literature review","volume":"3","author":"Neetu","year":"2010","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.breast.2011.02.019_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2337\/diacare.25.1.121","article-title":"\u201cDiabetic mastopathy\u201d, or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes","volume":"25","author":"Kudva","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.breast.2011.02.019_bib23","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/0046-8177(92)90348-7","article-title":"Diabetic mastopathy: a distinctive clinicopathologic entity","volume":"23","author":"Tomaszewski","year":"1992","journal-title":"Hum Pathol"},{"key":"10.1016\/j.breast.2011.02.019_bib24","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0046-8177(94)90253-4","article-title":"Mastopathy in insulin-requiring diabetes mellitus","volume":"25","author":"Seidman","year":"1994","journal-title":"Hum Pathol"},{"key":"10.1016\/j.breast.2011.02.019_bib25","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1524-4741.2007.00489.x","article-title":"The diagnosis and management of diabetic mastopathy","volume":"13","author":"Thorncroft","year":"2007","journal-title":"Breast J"},{"key":"10.1016\/j.breast.2011.02.019_bib26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.breast.2004.04.001","article-title":"Dynamic contrast enhanced magnetic resonance imaging and magnetic resonance spectroscopy in diabetic mastopahy","volume":"14","author":"Balan","year":"2005","journal-title":"Breast"},{"key":"10.1016\/j.breast.2011.02.019_bib27","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archsurg.135.10.1190","article-title":"Diabetic mastopathy: a report of 5 cases and a review of the literature","volume":"135","author":"Camuto","year":"2000","journal-title":"Arch Surg"},{"key":"10.1016\/j.breast.2011.02.019_bib28","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/01.pas.0000213284.27789.a8","article-title":"Diabetic (lymphocytic) mastopathy with exuberant lymphohistiocytic and granulomatous response: a case report with review of the literature","volume":"30","author":"Fong","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.breast.2011.02.019_bib29","article-title":"An uncommon case of T1b breast cancer with diabetic mastopathy in type II diabetes mellitus","author":"Hamashita","year":"2009","journal-title":"Breast Cancer"},{"key":"10.1016\/j.breast.2011.02.019_bib30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.breast.2004.09.016","article-title":"Breast carcinoma in diabetic mastopathy","volume":"14","author":"Mackey","year":"2005","journal-title":"Breast"},{"key":"10.1016\/j.breast.2011.02.019_bib31","first-page":"13","article-title":"Calcification in breast arteries. The frequency and severity of arterial calcification in female breast tissue without malignant changes","volume":"93","author":"Nielsen","year":"1985","journal-title":"Acta Pathol Microbiol Immunol Scand"},{"key":"10.1016\/j.breast.2011.02.019_bib32","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/gme.0b013e3181405d0a","article-title":"Breast arterial calcifications (BACs) found on screening mammography and their association with cardiovascular disease","volume":"15","author":"Rotter","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.breast.2011.02.019_bib33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1148\/radiology.201.1.8816524","article-title":"Breast arterial calcifications: association with diabetes mellitus and cardiovascular mortality. Work in progress","volume":"201","author":"Kemmeren","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.breast.2011.02.019_bib34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/oxfordjournals.aje.a009455","article-title":"Arterial calcification found on breast cancer screening mammograms and cardiovascular mortality in women: the DOM project. Doorlopend Onderzoek Morbiditeit en Mortaliteit","volume":"147","author":"Kemmeren","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.breast.2011.02.019_bib35","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jss.2008.11.837","article-title":"Mammography as a screening tool for diabetes","volume":"159","author":"Dale","year":"2010","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.breast.2011.02.019_bib36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2214\/AJR.05.0365","article-title":"How predictive is breast arterial calcification on cardiovascular disease and risk factors when found at screening mammography?","volume":"187","author":"Kataoka","year":"2006","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.breast.2011.02.019_bib37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/hrt.2005.065953","article-title":"Arterial calcium on mammograms is not associated with inflammatory markers for heart disease risk","volume":"92","author":"Maas","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.breast.2011.02.019_bib38","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1590\/S1807-59322009000800009","article-title":"Vascular calcifications seen on mammography: an independent factor indicating coronary artery disease","volume":"64","author":"Oliviera","year":"2009","journal-title":"Clin (Sao Paulo)"},{"issue":"59","key":"10.1016\/j.breast.2011.02.019_bib39","first-page":"225","article-title":"Cancer statistics","volume":"2009","author":"Jemal","year":"2009","journal-title":"CA Cancer J\u00a0Clin"},{"key":"10.1016\/j.breast.2011.02.019_bib40","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","article-title":"Estimates of cancer incidence and mortality in Europe in 2008","volume":"46","author":"Ferlay","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2011.02.019_bib41","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2337\/diacare.26.6.1752","article-title":"Type 2 diabetes and subsequent incidence of breast cancer in the Nurses\u2019 Health Study","volume":"26","author":"Michels","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.breast.2011.02.019_bib42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10549-006-9172-5","article-title":"Diabetes mellitus and breast cancer: a retrospective population-based cohort study","volume":"98","author":"Lipscombe","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2011.02.019_bib43","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.293.2.194","article-title":"Fasting serum glucose level and cancer risk in Korean men and women","volume":"293","author":"Jee","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2011.02.019_bib44","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00125-006-0207-6","article-title":"Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria","volume":"49","author":"Rapp","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.breast.2011.02.019_bib45","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/aje\/kwh161","article-title":"Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults","volume":"159","author":"Coughlin","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.breast.2011.02.019_bib46","first-page":"673","article-title":"Cancer mortality among diabetics","volume":"44","author":"Kessler","year":"1970","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2011.02.019_bib47","article-title":"Diabetes and prognosis in a breast cancer cohort","author":"Schrauder","year":"2010","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.breast.2011.02.019_bib48","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1200\/JCO.2010.29.3183","article-title":"Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer","volume":"29","author":"Erickson","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2011.02.019_bib49","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-007-9654-0","article-title":"The impact of diabetes on survival following breast cancer","volume":"109","author":"Lipscombe","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2011.02.019_bib50","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10549-010-0732-3","article-title":"Medical comorbidities predict mortality in women with a history of early stage breast cancer","volume":"122","author":"Patterson","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2011.02.019_bib51","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.26.4.1047","article-title":"Mortality from site-specific malignancies in type 2 diabetic patients from Verona","volume":"26","author":"Verlato","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.breast.2011.02.019_bib52","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/sj.bjc.6602611","article-title":"Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study","volume":"92","author":"Swerdlow","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2011.02.019_bib53","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1200\/JCO.2008.17.5935","article-title":"Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer","volume":"27","author":"Srokowski","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2011.02.019_bib54","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/ijc.22532","article-title":"Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis","volume":"120","author":"van de Poll-Franse","year":"2007","journal-title":"Int J\u00a0Cancer"},{"key":"10.1016\/j.breast.2011.02.019_bib55","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10549-005-0324-9","article-title":"Racial disparities in treatment and survival of women at stage I-III breast cancer at a large academic medical center in metropolitan Detroit","volume":"91","author":"Du","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2011.02.019_bib56","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.285.7.885","article-title":"Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older","volume":"285","author":"Yancik","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2011.02.019_bib57","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.294.14.1765","article-title":"Comorbidity and survival disparities among black and white patients with breast cancer","volume":"294","author":"Tammemagi","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2011.02.019_bib58","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1200\/JCO.2009.27.3011","article-title":"Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis","volume":"29","author":"Peairs","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2011.02.019_bib59","first-page":"745","article-title":"Preoperative core needle biopsy as an independent risk factor for wound infection after breast surgery","volume":"101","author":"Witt","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.breast.2011.02.019_bib60","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PRS.0b013e3181da878f","article-title":"Irradiated autologous breast reconstructions: effects of patient factors and treatment variables","volume":"126","author":"Albino","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.breast.2011.02.019_bib61","first-page":"160","article-title":"Tamoxifen-induced hypertriglyceridemia in association with diabetes mellitus","volume":"27","author":"Milionis","year":"2001","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.breast.2011.02.019_bib62","first-page":"207","article-title":"Diabetes and cancer: a consensus report","volume":"60","author":"Giovannucci","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.breast.2011.02.019_bib63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/13813450801954451","article-title":"Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies","volume":"114","author":"Pisani","year":"2008","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.breast.2011.02.019_bib64","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1470-2045(05)01736-5","article-title":"Diabetes mellitus and breast cancer","volume":"6","author":"Wolf","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2011.02.019_bib65","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1467-789X.2007.00396.x","article-title":"Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer","volume":"8","author":"Vona-Davis","year":"2007","journal-title":"Obes Rev"},{"key":"10.1016\/j.breast.2011.02.019_bib66","doi-asserted-by":"crossref","first-page":"s823","DOI":"10.1093\/ajcn\/86.3.823S","article-title":"Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence","volume":"86","author":"Xue","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.breast.2011.02.019_bib67","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1055\/s-0030-1254116","article-title":"Breast cancer and diabetes mellitus","volume":"118","author":"Schott","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.breast.2011.02.019_bib68","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1470-2045(10)70095-4","article-title":"Insulin-like growth factor 1 (IGF-1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies","volume":"11","author":"Key","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2011.02.019_bib69","doi-asserted-by":"crossref","first-page":"38023","DOI":"10.1074\/jbc.M104416200","article-title":"Effect of insulin on cell cycle progression in MCF-7 breast cancer cells Direct and potentiating influence","volume":"276","author":"Chappell","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.breast.2011.02.019_bib70","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jcp.1041340112","article-title":"Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen","volume":"134","author":"van der Burg","year":"1988","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.breast.2011.02.019_bib71","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1172\/JCI114868","article-title":"Elevated insulin receptor content in human breast cancer","volume":"86","author":"Papa","year":"1990","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.breast.2011.02.019_bib72","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","article-title":"PI3K\/Akt signalling pathway and cancer","volume":"30","author":"Fresno Vara","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.breast.2011.02.019_bib73","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jcem-69-5-946","article-title":"Androgens and estrogens in postmenopausal insulin-treated diabetic women","volume":"69","author":"Nyholm","year":"1989","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.breast.2011.02.019_bib74","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","article-title":"Endogenous hormones and breast cancer collaborative group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies","volume":"94","author":"Key","year":"2002","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2011.02.019_bib75","first-page":"985","article-title":"Leptin receptor expression and cell signaling in breast cancer","volume":"28","author":"Frankenberry","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1016\/j.breast.2011.02.019_bib76","first-page":"5699","article-title":"Association of serum adiponectin levels with breast cancer risk","volume":"9","author":"Miyoshi","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.breast.2011.02.019_bib77","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1210\/jc.2003-031804","article-title":"Adiponectin and breast cancer risk","volume":"89","author":"Mantzoros","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.breast.2011.02.019_bib78","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/156800909787314002","article-title":"The urokinase plasminogen activator system: a target for anti-cancer therapy","volume":"9","author":"Ulisse","year":"2009","journal-title":"Curr Cancer Drugs Targets"},{"key":"10.1016\/j.breast.2011.02.019_bib79","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s00125-009-1418-4","article-title":"Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study","volume":"52","author":"Grouven","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.breast.2011.02.019_bib80","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00125-009-1444-2","article-title":"Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden","volume":"52","author":"Jonasson","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.breast.2011.02.019_bib81","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s00125-009-1453-1","article-title":"Use of insulin glargine and cancer incidence in Scotland: a study from Scottish diabetes research Network Epidemiology group","volume":"52","author":"Colhoun","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.breast.2011.02.019_bib82","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00125-009-1530-5","article-title":"Combined randomized controlled trial experience of malignancies in studies using insulin glargine","volume":"52","author":"Home","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.breast.2011.02.019_bib83","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2337\/diacare.29.02.06.dc05-1558","article-title":"Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin","volume":"29","author":"Bowker","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.breast.2011.02.019_bib84","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","article-title":"The influence of glucose-lowering therapies on cancer risk in type 2 diabetes","volume":"52","author":"Currie","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.breast.2011.02.019_bib85","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/jama.2010.60","article-title":"Does insulin therapy promote, reduce, or have a neutral effect on cancers?","volume":"303","author":"Gerstein","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2011.02.019_bib86","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(10)61374-8","article-title":"ISICA group","volume":"376","author":"Grimaldi-Bensouda","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2011.02.019_bib87","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1517\/14656560903176453","article-title":"Metformin: diamonds are forever","volume":"10","author":"Papanas","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.breast.2011.02.019_bib88","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2337\/dc08-2175","article-title":"New users of metformin are at low risk for incident cancer: a cohort study among people with type 2 diabetes","volume":"32","author":"Libby","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.breast.2011.02.019_bib89","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.breast.2011.02.019_bib90","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2337\/dc09-1791","article-title":"Long-term metformin use is associated with decreased risk of breast cancer","volume":"33","author":"Bodmer","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.breast.2011.02.019_bib91","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1158\/1055-9965.EPI-10-0817","article-title":"Metformin and\u00a0incident breast cancer among diabetic women: a population-based case-control study in Denmark","volume":"20","author":"Bosco","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.breast.2011.02.019_bib92","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.breast.2011.02.019_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2008.01.007","article-title":"Targeting AMPK: a new therapeutic opportunity in the breast cancer","volume":"67","author":"Hadad","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.breast.2011.02.019_bib94","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1200\/JCO.2009.22.1630","article-title":"Metformin in breast cancer: time for action","volume":"27","author":"Goodwin","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2011.02.019_bib95","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1530\/EJE-07-0815","article-title":"Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes","volume":"158","author":"Lund","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.breast.2011.02.019_bib96","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1200\/JCO.2008.18.9068","article-title":"Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients","volume":"27","author":"Pierce","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2011.02.019_bib97","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","article-title":"Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission","volume":"69","author":"Hirsch","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2011.02.019_bib98","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4161\/cc.8.6.7933","article-title":"Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro","volume":"8","author":"Alimova","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.breast.2011.02.019_bib99","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.4161\/cc.8.10.8406","article-title":"Genome-wide inhibitory impact of the AMPK activator metformin on kinesins, tubulins, histones, auroras and polo-like kinases M-phase cell cycle genes in human breast cancer cells","volume":"8","author":"Oliveras-Ferraros","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.breast.2011.02.019_bib100","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2337\/dc09-1380","article-title":"Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16","volume":"33","author":"Landman","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.breast.2011.02.019_bib101","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1200\/JCO.2009.19.6410","article-title":"Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer","volume":"27","author":"Jiralerspong","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2011.02.019_bib102","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1200\/JCO.2002.20.1.42","article-title":"Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study","volume":"20","author":"Goodwin","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2011.02.019_bib103","first-page":"27","article-title":"Metformin as an addition to conventional chemotherapy in breast cancer","author":"Grenader","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2011.02.019_bib104","unstructured":"Clinical and Biologic effects of metformin in early stage breast cancer NCT00897884 http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00897884?term=breast\u00b1cancer\u00b1metformin&rank=2 [accessed 31.01.11]."},{"key":"10.1016\/j.breast.2011.02.019_bib105","unstructured":"Metformin Hydrochloride in treating women with stage I or stage II breast cancer that can Be removed by surgery NCT00984490 http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00984490?term=breast\u00b1cancer\u00b1metformin&rank=3[accessed 31.01.11]."},{"key":"10.1016\/j.breast.2011.02.019_bib106","unstructured":"Metformin Hydrochloride in treating patients with early-stage breast cancer\u00a0NCT01101438 http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01101438?term=metformin\u00b1breast\u00b1cancer&rank=4. [accessed 31.01.11]."},{"key":"10.1016\/j.breast.2011.02.019_bib107","unstructured":"Efficacy and safety of adjuvant metformin for operable breast cancer patients\u00a0NCT00909506. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00909506?term=metformin\u00b1breast\u00b1cancer&rank=6. [accessed 31.11]."},{"key":"10.1016\/j.breast.2011.02.019_bib108","unstructured":"Metformin pre-surgical Pilot study NCT00930579. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00930579?term=metformin+breast+cancer&rank=7 [accessed 31.01.11]"},{"key":"10.1016\/j.breast.2011.02.019_bib109","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/dmrr.736","article-title":"Are sulfonylureas all the same? A cohort study on cardiovascular and cancer-related mortality","volume":"23","author":"Monami","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.breast.2011.02.019_bib110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00592-008-0083-2","article-title":"Sulfonylureas and cancer: a case-control study","volume":"46","author":"Monami","year":"2009","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.breast.2011.02.019_bib111","first-page":"967","article-title":"Peroxisome proliferator-activated receptor gamma activation in human breast cancer","volume":"15","author":"Lee","year":"1999","journal-title":"Int J\u00a0Oncol"},{"key":"10.1016\/j.breast.2011.02.019_bib112","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1097-2765(00)80047-7","article-title":"Terminal differentiation of human breast cancer through PPAR gamma","volume":"1","author":"Mueller","year":"1998","journal-title":"Mol Cell"},{"key":"10.1016\/j.breast.2011.02.019_bib113","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1023\/A:1022978608125","article-title":"The antiproliferative effects of PPARgamma ligands in normal human mammary epithelial cells","volume":"78","author":"Lee","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2011.02.019_bib114","first-page":"2170","article-title":"Ligands for peroxisome proliferator-activated recepror gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells","volume":"86","author":"Ohta","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.breast.2011.02.019_bib115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1741-7015-5-17","article-title":"Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System","volume":"5","author":"Ramos-Nino","year":"2007","journal-title":"BMC Med"},{"key":"10.1016\/j.breast.2011.02.019_bib116","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2337\/dc07-2308","article-title":"Rosiglitazone and risk of cancer: a meta-analysis of randomized clinical trials","volume":"31","author":"Monami","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.breast.2011.02.019_bib117","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/pds.1352","article-title":"Cancer risk in thiazolidinedione users compared to other anti-diabetic agents","volume":"16","author":"Koro","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.breast.2011.02.019_bib118","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1158\/1078-0432.CCR-06-1947","article-title":"Pilot study of rosiglitazone therapy in women with breast cancer: effects of short-term therapy on tumor tissue and serum markers","volume":"13","author":"Yee","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.breast.2011.02.019_bib119","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00002018-200932030-00002","article-title":"van Troostenburg de Bruyn AR; PROactive investigators","volume":"32","author":"Dormandy","year":"2009","journal-title":"Drug Saf"},{"key":"10.1016\/j.breast.2011.02.019_bib120","doi-asserted-by":"crossref","first-page":"159415","DOI":"10.1155\/2008\/159415","article-title":"Clinical use of PPARgamma ligands in cancer","volume":"2008","author":"Hatton","year":"2008","journal-title":"PPAR Res"},{"key":"10.1016\/j.breast.2011.02.019_bib121","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2337\/db09-1291","article-title":"Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression","volume":"59","author":"Fierz","year":"2010","journal-title":"Diabetes"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977611000555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977611000555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:28:03Z","timestamp":1760776083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977611000555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":121,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0960977611000555"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2011.02.019","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The female breast and diabetes","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2011.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}